Now, it is starting the next leg of a rally where Rs 210 is an immediate multi-month resistance level. We are expecting a move towards the Rs 230 level if the stock manages to close above Rs 210. On the downside, Rs 175 is major support for any correction.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.